Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,871,600 | 3,165,800 | 3,765,700 | 3,888,000 | 3,830,200 |
| Marketable Securities | 955,400 | 1,644,100 | 1,360,800 | 1,324,400 | 1,567,100 |
| Receivables | 3,801,300 | 3,634,600 | 3,754,100 | 3,746,100 | 4,022,800 |
| Inventories | 2,740,000 | 2,844,500 | 3,190,300 | 2,969,000 | 2,928,800 |
| TOTAL | $11,928,300 | $12,110,500 | $13,156,700 | $13,039,300 | $13,104,700 |
| Non-Current Assets | |||||
| PPE Net | 7,963,900 | 8,043,300 | 8,100,900 | 7,970,700 | 7,975,500 |
| Investments And Advances | 4,568,900 | 7,405,500 | 6,649,700 | 7,204,800 | 7,624,900 |
| Intangibles | 2,884,200 | 0 | 0 | 0 | 2,814,300 |
| Other Non-Current Assets | 8,962,300 | 7,089,500 | 7,111,100 | 6,542,100 | 3,729,300 |
| TOTAL | $24,379,300 | $22,538,300 | $21,861,700 | $21,717,600 | $22,144,000 |
| Total Assets | $36,307,600 | $34,648,800 | $35,018,400 | $34,756,900 | $35,248,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 9,100 | N/A |
| Accounts payable and accrued liabilities | 1,128,100 | 1,023,300 | 1,124,600 | 1,149,900 | 1,119,300 |
| Other current liabilities | 5,300,400 | 4,732,300 | 4,545,400 | 4,609,800 | 5,214,000 |
| TOTAL | $9,741,000 | $7,574,600 | $7,417,400 | $6,631,700 | $8,916,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,332,800 | 5,292,600 | 5,301,000 | 5,255,300 | 4,200,300 |
| Other Non-Current Liabilities | 5,845,700 | 4,099,100 | 4,305,200 | 4,521,200 | 4,491,099 |
| TOTAL | $11,178,500 | $9,391,700 | $9,606,200 | $9,776,500 | $8,691,399 |
| Total Liabilities | $20,919,500 | $16,966,300 | $17,023,600 | $16,408,200 | $17,608,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,111,104 | 1,113,430 | 1,117,308 | 1,119,451 | 1,119,713 |
| Common Shares | 694,600 | 696,600 | 699,000 | 700,100 | 698,500 |
| Retained earnings | 16,482,700 | 17,406,900 | 17,204,300 | 17,665,300 | 16,992,400 |
| Other shareholders' equity | -6,990,500 | -5,552,000 | -4,937,800 | -4,960,300 | -5,006,200 |
| TOTAL | $15,388,100 | $17,682,500 | $17,994,800 | $18,348,700 | $17,640,700 |
| Total Liabilities And Equity | $36,307,600 | $34,648,800 | $35,018,400 | $34,756,900 | $35,248,700 |